| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Business Management Case Study; Disgruntled Terminated Franchisees and a Moral Mission |
|
Advice You - Business Management Case Study; Disgruntled Terminated Franchisees and a Moral Mission
Franchising executives need to be careful to hand terminated and disgruntled franchisees with s According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product pecial care because a franchisee who feels that they have been wronged or decides to act on rev ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in enge can cause a franchise system a whole lot of problems. Often they will start calling up Sta lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. te and Federal Regulatory Bodies and complaining about the company. Harassing current franchise here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe s and bad mouthing the company in the industry are also extremely common. Why does this occur? d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro Well, I have given this some thought over the years and it appears to be an innate characteris ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc tics of mankind actually that people who are disrespected often seek revenge. This of course ca easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi be completely unfortunate for a brand name although allowing a non-performing, under capitaliz nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ed or defaulting franchisee can also hurt the brand name. The better move is to help the franch and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ isee come into compliance any way you can. Nevertheless, be ready for the rogue franchisee who ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi oes postal. They will say things like I want to teach them a lesson when speaking of the franc ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a hising company or “My biggest fear is that I won't be able to stop them before they hurt any on dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod e else.” They make it a moral mission and crusade and refuse to take fault for any of it someho cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin w convincing themselves that they have a right to misrepresent the situation, slander the franc tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen isor and modify the truth of events. Franchisors must protect their brand name from these peo t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ple and be careful to lay all the facts out for the State and Federal Regulators when they file ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust complaints. Franchisors are always considered guilty until they prove themselves innocent even y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products though it is a proven fact that 85% of all complaints in franchising to government agencies are . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de falsehoods, misrepresentations of fact or out right fraudulent. That is the true percentage an elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip d franchisors need to consider this fall-out from terminated franchisees. Think on this in 2006 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Looking for a Great Deal on Toner? Tips for Buying Toner Online
|